MedTrace Logo

Physiotherapy Applications in Upper Extremity Lipedema

NCT04643392 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 14

Last updated 2020-11-25

No results posted yet for this study

Summary

Lipedema which causes excessive accumulation of fat in the subcutaneous tissue, is a rare, progressive disease. This disease generally affects women, following puberty or early adulthood and usually results in the slow increase of the circumference of the legs and/or arms, bilaterally. In a typical presentation of lipedema, the enlargement of the lower extremities is disproportionately greater than that of the trunk and upper extremities When first described in 1940, lipedema was thought to exclusively affect the lower extremities. However, as the disease has been recognized over the years, lipedema has been reported to affect the upper extremities. Upper extremity lipedema, with no involvement of the lower extremities is an extremely rare incident.

Conditions

  • Lipedema

Interventions

PROCEDURE

Complex decongestive physiotherapy

Each patient received a treatment protocol of Complex decongestive physiotherapy for 5 days a week until they were discharged from the clinic. All patients fully completed all components of the treatment routine daily. The treatment was performed by a physiotherapist who was certified with Manual Lymph Drainage Combined Decongestive Physiotherapy. After the daily treatment protocol was completed, patients wore standard or individually sized compression grade II or III medical compression stockings for the rest of the day.

Sponsors & Collaborators

  • Yuksek Ihtisas University

    lead OTHER

Principal Investigators

  • Melek Volkan-Yazici, PT. PhD · Yuksek Ihtisas University

  • Murat Esmer, PT. MSc · Gazi University

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-02
Primary Completion
2020-02-03
Completion
2020-05-04

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04643392 on ClinicalTrials.gov